Some links on our site may earn us a commission at no extra cost to you. Learn more.
Medical Disclaimer: We are not doctors, pharmacists, or medical professionals, and nothing you read here is medical advice. This content is for general informational and educational purposes only. GLP-1 medications are prescription-only treatments — always consult a licensed healthcare provider before starting, stopping, or changing any medication or weight loss program. Compounded medications are not FDA-approved. Individual results vary, and weight loss is never guaranteed.
The single most important thing to understand before signing up for any online GLP-1 program is the difference between brand-name and compounded medication. It’s the difference between paying $1,300 a month and $150 a month — and it’s also a difference in regulatory oversight that every honest program will tell you about upfront. Here’s the full picture.
Prices are approximate, current as of publication, and change frequently — confirm the latest price with the retailer before buying.
What “brand-name” means
Brand-name GLP-1s — Ozempic and Wegovy (semaglutide, made by Novo Nordisk) and Mounjaro and Zepbound (tirzepatide, made by Eli Lilly) — are FDA-approved products. That approval means the finished product went through large clinical trials and the FDA reviewed its safety, effectiveness, and manufacturing quality before it could be sold. Every pen or vial comes off a tightly controlled manufacturing line. The trade-off is price: without insurance, brand-name GLP-1s typically retail between roughly $900 and $1,350 per month.
What “compounded” means
Compounded semaglutide or tirzepatide is prepared by a licensed compounding pharmacy using the same class of active ingredient, mixed for an individual patient based on a prescription. Compounding itself is a legal, long-established part of American pharmacy, regulated at the state and federal level. Pharmacies doing this work fall into two categories: 503A pharmacies (state-regulated, preparing patient-specific prescriptions) and 503B outsourcing facilities (FDA-registered and subject to federal manufacturing standards).
Here is the sentence that matters most, and that reputable telehealth platforms like Wellorithm print on their own websites: compounded medications have not been reviewed or approved by the FDA for safety, effectiveness, or quality. The active ingredient class is the same one studied in the big clinical trials — but the specific compounded product you receive was never itself put through FDA review.
What the FDA has actually said
The FDA has published consumer guidance raising concerns about some unapproved GLP-1 products marketed for weight loss. The specific issues flagged include dosing errors with compounded injectables (patients drawing up the wrong amount from multi-dose vials), improper refrigeration during shipping, and some products using semaglutide salt forms — chemical variants that are not the same active ingredient as the FDA-approved reference drugs. None of this means all compounded GLP-1s are dangerous; it means sourcing and pharmacy quality genuinely matter, and it’s why we treat pharmacy transparency as a top criterion when reviewing any program.
The price gap, in real numbers
Current published starting prices illustrate why compounded options dominate the telehealth market. Wellorithm lists compounded semaglutide from $147 per month and tirzepatide from $249. TrimRX lists compounded semaglutide from about $174 per month on a 12-month plan, with tirzepatide from about $283. Brightmeds starts compounded semaglutide around $189 per month and also sells FDA-approved Zepbound pens and vials at premium pricing for patients who want the brand-name route. Against a $1,349 retail price for brand-name Wegovy, a compounded plan can cut the monthly cost by 80–90%.
How to think about the choice
There’s no universal right answer — there’s a right answer for your budget, your risk tolerance, and your clinician’s judgment. Some rough contours:
- Brand-name makes sense if insurance covers it, if you qualify for a manufacturer savings program, or if FDA approval of the finished product is non-negotiable for you.
- Compounded makes sense if you’re paying cash, the brand-name price is simply out of reach, and you’ve chosen a platform that names its pharmacy partners, ships with temperature control, and is transparent about FDA status. Certifications like LegitScript (which Brightmeds holds) add a meaningful layer of vetting.
- Either way, the decision of which medication — if any — is appropriate belongs to a licensed clinician who has reviewed your health history. Full stop.
Questions to ask any program before you pay
- Which pharmacy fills the prescriptions, and is it a 503A or 503B facility?
- Is the product semaglutide/tirzepatide base, or a salt form?
- How is the medication shipped and temperature-protected?
- What happens to my payment if the clinician doesn’t approve me?
- What does the price include — consultations, dose changes, supplies, shipping?
A platform that answers all five clearly is showing you respect. A platform that dodges them is showing you something too. For how the whole telehealth process works end to end, see our step-by-step telehealth guide, and for what you’ll actually spend over a year, our GLP-1 cost breakdown.
